Literature DB >> 35586437

Thermal Stability and Utility of Dienes as Protecting Groups for Acrylamides.

Annie R Hooper1, Alexander S Burns2.   

Abstract

Acrylamides are privileged electrophiles used in targeted covalent therapies, often installed at the end of a synthetic sequence due to their reactive nature. Herein, we report several diene-acrylamide adducts with a range of thermal stabilities toward retro-Diels-Alder deprotection of the acrylamide, enabling this masked functionality to be introduced early in a synthetic route and deprotected in a specific temperature range. Through kinetic studies, we identify solvent and structural trends that impact the stability of trimethylsilyl cyclopentadiene (TMS-CP) acrylamide adducts. TMS-CP protected acrylamides were installed on several amine-containing drugs, whose acrylamides were thermally unveiled (T = 160 °C, time ≤ 1 h) in moderate to high yields. We also showcase the potential utility of this protection strategy by improving the yield of a base-promoted SNAr reaction when the acrylamide is masked.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35586437      PMCID: PMC9109275          DOI: 10.1021/acsmedchemlett.2c00075

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  26 in total

1.  Development of a multibed sorption trap, comprehensive two-dimensional gas chromatography, and time-of-flight mass spectrometry system for the analysis of volatile organic compounds in human breath.

Authors:  Juan M Sanchez; Richard D Sacks
Journal:  Anal Chem       Date:  2006-05-01       Impact factor: 6.986

2.  Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors.

Authors:  Mark E Flanagan; Joseph A Abramite; Dennis P Anderson; Ann Aulabaugh; Upendra P Dahal; Adam M Gilbert; Chao Li; Justin Montgomery; Stacey R Oppenheimer; Tim Ryder; Brandon P Schuff; Daniel P Uccello; Gregory S Walker; Yan Wu; Matthew F Brown; Jinshan M Chen; Matthew M Hayward; Mark C Noe; R Scott Obach; Laurence Philippe; Veerabahu Shanmugasundaram; Michael J Shapiro; Jeremy Starr; Justin Stroh; Ye Che
Journal:  J Med Chem       Date:  2014-11-26       Impact factor: 7.446

3.  Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR.

Authors:  Simon Planken; Douglas C Behenna; Sajiv K Nair; Theodore O Johnson; Asako Nagata; Chau Almaden; Simon Bailey; T Eric Ballard; Louise Bernier; Hengmiao Cheng; Sujin Cho-Schultz; Deepak Dalvie; Judith G Deal; Dac M Dinh; Martin P Edwards; Rose Ann Ferre; Ketan S Gajiwala; Michelle Hemkens; Robert S Kania; John C Kath; Jean Matthews; Brion W Murray; Sherry Niessen; Suvi T M Orr; Mason Pairish; Neal W Sach; Hong Shen; Manli Shi; James Solowiej; Khanh Tran; Elaine Tseng; Paolo Vicini; Yuli Wang; Scott L Weinrich; Ru Zhou; Michael Zientek; Longqing Liu; Yiqin Luo; Shuibo Xin; Chengyi Zhang; Jennifer Lafontaine
Journal:  J Med Chem       Date:  2017-03-29       Impact factor: 7.446

4.  BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.

Authors:  D Li; L Ambrogio; T Shimamura; S Kubo; M Takahashi; L R Chirieac; R F Padera; G I Shapiro; A Baum; F Himmelsbach; W J Rettig; M Meyerson; F Solca; H Greulich; K-K Wong
Journal:  Oncogene       Date:  2008-04-14       Impact factor: 9.867

5.  Bicyclobutane Carboxylic Amide as a Cysteine-Directed Strained Electrophile for Selective Targeting of Proteins.

Authors:  Keisuke Tokunaga; Mami Sato; Keiko Kuwata; Chizuru Miura; Hirokazu Fuchida; Naoya Matsunaga; Satoru Koyanagi; Shigehiro Ohdo; Naoya Shindo; Akio Ojida
Journal:  J Am Chem Soc       Date:  2020-10-13       Impact factor: 15.419

6.  Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase.

Authors:  Yunhang Guo; Ye Liu; Nan Hu; Desheng Yu; Changyou Zhou; Gongyin Shi; Bo Zhang; Min Wei; Junhua Liu; Lusong Luo; Zhiyu Tang; Huipeng Song; Yin Guo; Xuesong Liu; Dan Su; Shuo Zhang; Xiaomin Song; Xing Zhou; Yuan Hong; Shuaishuai Chen; Zhenzhen Cheng; Steve Young; Qiang Wei; Haisheng Wang; Qiuwen Wang; Lei Lv; Fan Wang; Haipeng Xu; Hanzi Sun; Haimei Xing; Na Li; Wei Zhang; Zhongbo Wang; Guodong Liu; Zhijian Sun; Dongping Zhou; Wei Li; Libin Liu; Lai Wang; Zhiwei Wang
Journal:  J Med Chem       Date:  2019-08-19       Impact factor: 7.446

7.  Asymmetric synthesis of beta-amino-gamma-substituted-gamma-butyrolactones: double diastereoselective conjugate addition of homochiral lithium amides to homochiral alpha,beta-unsaturated esters.

Authors:  Thaïs Cailleau; Jason W B Cooke; Stephen G Davies; Kenneth B Ling; Alan Naylor; Rebecca L Nicholson; Paul D Price; Paul M Roberts; Angela J Russell; Andrew D Smith; James E Thomson
Journal:  Org Biomol Chem       Date:  2007-10-24       Impact factor: 3.876

8.  Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors.

Authors:  Kirsten McAulay; Emily A Hoyt; Morgan Thomas; Marianne Schimpl; Michael S Bodnarchuk; Hilary J Lewis; Derek Barratt; Deepa Bhavsar; David M Robinson; Michael J Deery; Derek J Ogg; Gonçalo J L Bernardes; Richard A Ward; Michael J Waring; Jason G Kettle
Journal:  J Am Chem Soc       Date:  2020-06-02       Impact factor: 15.419

9.  AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.

Authors:  Darren A E Cross; Susan E Ashton; Serban Ghiorghiu; Cath Eberlein; Caroline A Nebhan; Paula J Spitzler; Jonathon P Orme; M Raymond V Finlay; Richard A Ward; Martine J Mellor; Gareth Hughes; Amar Rahi; Vivien N Jacobs; Monica Red Brewer; Eiki Ichihara; Jing Sun; Hailing Jin; Peter Ballard; Katherine Al-Kadhimi; Rachel Rowlinson; Teresa Klinowska; Graham H P Richmond; Mireille Cantarini; Dong-Wan Kim; Malcolm R Ranson; William Pao
Journal:  Cancer Discov       Date:  2014-06-03       Impact factor: 39.397

10.  Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35.

Authors:  Thomas C Atack; Donald D Raymond; Christa A Blomquist; Charisse Flerida Pasaje; Patrick R McCarren; Jamie Moroco; Henock B Befekadu; Foxy P Robinson; Debjani Pal; Lisl Y Esherick; Alessandra Ianari; Jacquin C Niles; William R Sellers
Journal:  ACS Med Chem Lett       Date:  2020-09-01       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.